Equities

Qingdao Haier Biomedical Co Ltd

688139:SHH

Qingdao Haier Biomedical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)25.24
  • Today's Change-10.45 / -29.28%
  • Shares traded1.57m
  • 1 Year change-36.18%
  • Beta1.7623
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,0162,9562,879
Total Receivables, Net238203173
Total Inventory248271346
Prepaid expenses223934
Other current assets, total121926
Total current assets2,5363,4893,457
Property, plant & equipment, net882817482
Goodwill, net643451323
Intangibles, net368312242
Long term investments1,040382358
Note receivable - long term--1.621.32
Other long term assets0.09----
Total assets5,5265,4894,900
LIABILITIES
Accounts payable286336281
Accrued expenses10411383
Notes payable/short-term debt111159151
Current portion long-term debt/capital leases3.425.481.65
Other current liabilities, total438571627
Total current liabilities9421,1841,144
Total long term debt8.69114.32
Total debt123175156
Deferred income tax474426
Minority interest20912816
Other liabilities, total8810287
Total liabilities1,2951,4681,277
SHAREHOLDERS EQUITY
Common stock318318317
Additional paid-in capital1,9871,9951,913
Retained earnings (accumulated deficit)2,0151,7511,309
Treasury stock - common(100)(98)--
Unrealized gain (loss)105484
Other equity, total0.29(0.12)(0.01)
Total equity4,2314,0213,623
Total liabilities & shareholders' equity5,5265,4894,900
Total common shares outstanding316317317
Treasury shares - common primary issue1.461.440
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.